MLYS Market Cap History Table | ||||||||||||
Also see: MLYS Shares Outstanding History and MLYS YTD Return |
MLYS Market Cap History Table | ||||||||||||
Also see: MLYS Shares Outstanding History and MLYS YTD Return |
MLYS Market Cap History Chart | |||||||||||||||
-18.90% CAGR Mouse over chart for data details
|
MLYS Stock Price Chart |
About Mineralys Therapeutics Inc |
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Co.'s product candidate, lorundrostat, is a proprietary, orally administered aldosterone synthase inhibitor that it is developing for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve blood pressure (BP) of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic. We show 5 historical shares outstanding datapoints in our MLYS shares outstanding history coverage, used to compute MLYS market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MLYS market cap history over the course of time is important for investors interested in comparing MLYS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MLYS versus a peer is one thing; comparing MLYS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MLYS can fluctuate over the course of history. With this page we aim to empower investors researching MLYS by allowing them to research the MLYS market cap history. |
MLYS Current Stock Quote |
Free MLYS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
MLYS Share Performance |
Market Cap Peers |
Mineralys Therapeutics (MLYS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
MMM Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.